Lower Merion Neurology Research Foundation

Lower Merion Neurology Research Foundation is a non-profit clinical research organization dedicated to the study and treatment of neurological disorders. Based in Pennsylvania and led by Dr. Sudhir Aggarwal, the foundation primarily focuses on conducting and sponsoring clinical trials to evaluate novel therapeutic interventions. A key area of their research involves investigating the neuroprotective effects of intravenous ketamine in patients with acute ischemic stroke through the QUEST-KETA Phase 2 trial. The foundation works closely with the clinical practice Lower Merion Neurology PC to integrate advanced medical research into patient care for conditions such as Alzheimer's, Parkinson's, and multiple sclerosis.